Vaporized Cannabis for Chronic Pain Associated With Sickle Cell Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

May 12, 2017

Study Completion Date

May 19, 2017

Conditions
Sickle Cell Disease
Interventions
DRUG

Cannabis

Trial Locations (1)

94110

San Francisco General Hospital, San Francisco

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

University of Minnesota

OTHER

lead

University of California, San Francisco

OTHER

NCT01771731 - Vaporized Cannabis for Chronic Pain Associated With Sickle Cell Disease | Biotech Hunter | Biotech Hunter